Can MRI or Ultrasound Diagnose CIDP When Tests Are Unclear?
At a Glance
MRI and peripheral nerve ultrasound can provide supportive clues when CIDP nerve conduction studies are unclear, such as enlarged nerves or nerve-root changes. However, normal scans do not rule out CIDP, and abnormal findings cannot confirm it without clinical and electrodiagnostic evaluation.
In this answer
3 sections
When standard nerve conduction studies (NCS) do not provide a clear answer, specialized MRI and peripheral nerve ultrasound can be valuable tools to help evaluate for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [1]. These imaging tests can reveal physical changes in your nerves, providing extra clues for your doctor [2][3]. However, imaging serves only as a supportive test alongside your clinical symptoms and electrodiagnostic results (nerve conduction and muscle electrical testing) [1]. It does not replace the need for electrodiagnostic testing, and it cannot confirm or rule out CIDP on its own [4][1].
What Can Imaging Show in CIDP?
Both MRI and ultrasound look at the physical structure of your nerves, rather than how well electrical signals travel through them.
- Nerve Ultrasound: This test uses sound waves (involving no ionizing radiation) to create pictures of your peripheral nerves. In people with CIDP, ultrasound often shows an increased cross-sectional area (CSA), meaning the nerves are swollen or enlarged [2]. However, ultrasound has limitations: measurements can vary based on the equipment, the examiner, and the specific nerve being tested, and deep nerve roots are harder to see than superficial nerves [5]. Therefore, scans should be performed by a specialist trained in neuromuscular ultrasound [5].
- MR Neurography (Dedicated Nerve MRI): A standard routine MRI is often not enough to see nerve details. Doctors use a specialized protocol called MR neurography to look deep into the body at the nerve roots (where nerves exit the spine) and the nerve networks (plexuses) in the shoulder and pelvis [3]. In CIDP, an MRI might show nerve root enlargement or changes in tissue signal [3]. Sometimes, doctors use gadolinium contrast, an intravenous dye. If the nerves show “enhancement” after the dye is given, it suggests a disruption in the blood-nerve barrier, which may support an inflammatory neuropathy but does not definitively prove active inflammation [3][6]. (Note: MRI is loud, requires lying still in a tube, and may not be safe for people with certain metal implants. The need for contrast should involve a discussion of kidney function and potential risks with your doctor.)
The Limitations of Imaging
While these findings can be helpful, it is important to understand what imaging cannot do.
- Normal imaging does not rule out CIDP: You can have CIDP even if your MRI or ultrasound looks completely normal. Studies show that a significant number of people who are eventually diagnosed with CIDP have normal scans, so neither a normal MRI nor a normal ultrasound rules CIDP in or out [7][4].
- Findings are not specific to CIDP: Swollen or inflamed nerves are not unique to CIDP. Other conditions can cause similar nerve enlargement, such as Charcot-Marie-Tooth (CMT) disease (a genetic nerve disorder), severe diabetic neuropathy, or POEMS syndrome (a rare multisystem disorder that affects nerves and other organs) [8][9]. Because these findings overlap with other disorders, imaging cannot definitively distinguish CIDP from these mimics on its own [8].
- Imaging does not guarantee a diagnosis: According to international diagnostic guidelines, imaging provides “supportive evidence” [1]. If your clinical picture and nerve tests suggest “possible” CIDP, abnormal imaging may strengthen the case, but it does not automatically establish a definite CIDP diagnosis [1].
What to Do If Your Diagnosis is Uncertain
If your initial nerve conduction studies are inconclusive, the choice and timing of next steps are individualized. Your neurologist will choose a sequence based on your examination and potential alternative diagnoses. They may consider:
- Repeating or Expanding Nerve Tests: Your neurologist might recommend a more comprehensive electrodiagnostic study to examine additional nerves [10]. They may also use advanced techniques, like proximal stimulation or late responses, to evaluate nerve function closer to the spine where technically feasible [10].
- Cerebrospinal Fluid (CSF) Testing: A lumbar puncture (spinal tap) can check for elevated protein in the fluid around your spinal cord [11]. High protein without an elevated white blood cell count can support a CIDP diagnosis, but it is not specific to CIDP and can be caused by age, diabetes, or spinal stenosis [11]. A lumbar puncture carries its own risks, is not required for every patient, and cannot establish CIDP alone [11].
Common questions in this guide
Can an MRI or nerve ultrasound confirm CIDP on its own?
What might a nerve ultrasound show in CIDP?
Is MR neurography different from a routine MRI for CIDP?
What should happen if my nerve conduction studies are inconclusive?
Can enlarged nerves on imaging be caused by something besides CIDP?
Does an MRI for suspected CIDP require gadolinium contrast?
One line in your results can change your plan.
If nerve conduction studies are inconclusive, your care team will choose next steps, which may include spinal fluid testing. We check your results against the latest research to help you prepare for what’s next.
Related questions
Show more
Get notified when new evidence is published on Chronic inflammatory demyelinating polyneuropathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (11)
- 1
Tips in navigating the diagnostic complexities of chronic inflammatory demyelinating polyradiculoneuropathy.
Lewis RA, van Doorn PA, Sommer C
Journal of the neurological sciences 2022; (443()):120478 doi:10.1016/j.jns.2022.120478.
PMID: 36368137 - 2
Nerve Ultrasound Predicts Treatment Response in Chronic Inflammatory Demyelinating Polyradiculoneuropathy-a Prospective Follow-Up.
Härtig F, Ross M, Dammeier NM, et al.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2018; (15(2)):439-451 doi:10.1007/s13311-018-0609-4.
PMID: 29435815 - 3
Magnetic Resonance Imaging of Nerve Roots in the Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - A Systematic Review and Meta-Analysis.
Gausmann KM, May RA, Sichtermann T, et al.
European journal of neurology 2026; (33(5)):e70612 doi:10.1111/ene.70612.
PMID: 42205005 - 4
Contribution of plexus MRI in the diagnosis of atypical chronic inflammatory demyelinating polyneuropathies.
Lozeron P, Lacour MC, Vandendries C, et al.
Journal of the neurological sciences 2016; (360()):170-5.
PMID: 26723995 - 5
High-Resolution Nerve Ultrasound to Assess Nerve Echogenicity, Fascicular Count, and Cross-Sectional Area Using Semiautomated Analysis.
Gamber D, Motte J, Kerasnoudis A, et al.
Journal of neuroimaging : official journal of the American Society of Neuroimaging 2020; (30(4)):493-502 doi:10.1111/jon.12717.
PMID: 32521091 - 6
Diagnostic usefulness of plexus magnetic resonance imaging in chronic inflammatory demyelinating polyradiculopathy without electrodiagnostic criteria of demyelination.
Fargeot G, Viala K, Theaudin M, et al.
European journal of neurology 2019; (26(4)):631-638 doi:10.1111/ene.13868.
PMID: 30431216 - 7
Prospective study of the additional benefit of plexus magnetic resonance imaging in the diagnosis of chronic inflammatory demyelinating polyneuropathy.
Jomier F, Bousson V, Viala K, et al.
European journal of neurology 2020; (27(1)):181-187 doi:10.1111/ene.14053.
PMID: 31348848 - 8
The Noninvasive Diagnostic Value of MRN for CIDP: A Research from Qualitative to Quantitative.
Feng Y, Su X, Zheng C, Lu Z
Spine 2020; (45(21)):1506-1512 doi:10.1097/BRS.0000000000003599.
PMID: 33035045 - 9
A comparative study of brachial plexus sonography and magnetic resonance imaging in chronic inflammatory demyelinating neuropathy and multifocal motor neuropathy.
Goedee HS, Jongbloed BA, van Asseldonk JH, et al.
European journal of neurology 2017; (24(10)):1307-1313 doi:10.1111/ene.13380.
PMID: 28762574 - 10
Comparison of the diagnostic accuracy of the 2021 EAN/PNS and 2010 EFNS/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy.
Doneddu PE, De Lorenzo A, Manganelli F, et al.
Journal of neurology, neurosurgery, and psychiatry 2022; (93(12)):1239-1246 doi:10.1136/jnnp-2022-329357.
PMID: 36190959 - 11
RELEVANCE OF DIAGNOSTIC INVESTIGATIONS IN CHRONIC INFLAMMATORY DEMYELINATING POLIRADICULONEUROPATHY: DATA FROM THE ITALIAN CIDP DATABASE.
Liberatore G, Manganelli F, Cocito D, et al.
Journal of the peripheral nervous system : JPNS 2020; doi:10.1111/jns.12378.
PMID: 32343015
This page explains how MRI and nerve ultrasound may support CIDP evaluation when nerve tests are unclear; it is for informational purposes only and does not constitute medical advice. Your neurologist should interpret your results and choose the next tests.